Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs. Issue 6 (13th April 2016) - Bernardi, Massimo; Carrabba, Matteo; Messina, Carlo; Milani, Raffaella; Sala, Elisa; Pavesi, Francesca; Gentner, Bernhard; Peccatori, Jacopo; Assanelli, Andrea; Marktel, Sarah; Corti, Consuelo; Forcina, Alessandra; et al.